Irritable Bowel Syndrome Trial, Recruiting NCT07094035 Sponsor: Adamas Biotech S.r.l. Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT07094035
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years
  • People who are able to understand and sign a consent form agreeing to take part
  • People who have tested negative for HIV
  • People who have tested negative for pregnancy
  • People who have had irritable bowel syndrome (IBS) symptoms for at least 3 months, with those symptoms first starting at least 6 months ago
  • People who have recurring stomach pain at least once a week, linked to two or more of the following: the act of going to the toilet, a change in how often bowel movements happen, or a change in the shape or consistency of stools (based on a standard set of diagnostic guidelines called Rome IV criteria)
  • People who have fewer than three bowel movements per week, and also experience at least one of the following in more than 25% of toilet visits: lumpy or hard stools, a feeling of not fully emptying the bowel, a feeling of blockage in the back passage, or needing to use physical methods to help pass stools (confirm with trial site)
  • People who are able to understand and follow the requirements of the study protocol

Who may not be able to join:

  • People who are currently pregnant
  • People who are currently breastfeeding
  • People who have tested positive for HIV
  • People who do not meet the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393483854114

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Adamas Biotech S.r.l.
Registry
ClinicalTrials.gov
Start date
30 July 2025
Est. completion
1 October 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Efficacy of the food supplement in the overall improvement of perceived gastrointestinal symptoms.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov